- Home
- PMCB vs MDJH Comparison
PMCB vs MDJH Comparison
Compare PMCB & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- MDJH
- Stock Information
- Founded
- PMCB 1996
- MDJH 2002
- Country
- PMCB United States
- MDJH United Kingdom
- Employees
- PMCB N/A
- MDJH N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- MDJH Real Estate
- Sector
- PMCB Health Care
- MDJH Finance
- Exchange
- PMCB Nasdaq
- MDJH Nasdaq
- Market Cap
- PMCB 15.8M
- MDJH 13.6M
- IPO Year
- PMCB N/A
- MDJH 2019
- Fundamental
- Price
- PMCB $1.76
- MDJH $0.67
- Analyst Decision
- PMCB
- MDJH
- Analyst Count
- PMCB 0
- MDJH 0
- Target Price
- PMCB N/A
- MDJH N/A
- AVG Volume (30 Days)
- PMCB 36.5K
- MDJH 78.7K
- Earning Date
- PMCB 09-17-2024
- MDJH 01-01-0001
- Dividend Yield
- PMCB N/A
- MDJH N/A
- EPS Growth
- PMCB N/A
- MDJH N/A
- EPS
- PMCB 0.54
- MDJH N/A
- Revenue
- PMCB N/A
- MDJH $114,849.00
- Revenue This Year
- PMCB N/A
- MDJH N/A
- Revenue Next Year
- PMCB N/A
- MDJH N/A
- P/E Ratio
- PMCB $3.31
- MDJH N/A
- Revenue Growth
- PMCB N/A
- MDJH 289.97
- 52 Week Low
- PMCB $1.39
- MDJH $0.59
- 52 Week High
- PMCB $2.58
- MDJH $2.19
- Technical
- Relative Strength Index (RSI)
- PMCB 48.48
- MDJH 36.17
- Support Level
- PMCB $1.72
- MDJH $0.62
- Resistance Level
- PMCB $1.95
- MDJH $0.67
- Average True Range (ATR)
- PMCB 0.26
- MDJH 0.05
- MACD
- PMCB -0.01
- MDJH 0.01
- Stochastic Oscillator
- PMCB 38.75
- MDJH 30.40
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About MDJH MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.